Evidence map›Paper›PMID 12446655›Full record

ArticleJournal of bacteriology2002

Alcaligin siderophore production by Bordetella bronchiseptica strain RB50 is not repressed by the BvgAS virulence control system.

Timothy J Brickman, Sandra K Armstrong

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of bacteriology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Timothy J BrickmanDepartment of Microbiology, University of Minnesota Medical School, Minneapolis 55455-0312, USA. brickman@lenti.med.umn.edu
Sandra K Armstrong
University of Minnesota Medical Center · US

Funding

IRON ACQUISITION IN BORDETELLA PERTUSSISR01AI031088 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ARMSTRONG, SANDRA KAY · 1998 to 2014
$3.2M
Iron acquistion in Bordetella pertussisR21AI031088 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ARMSTRONG, SANDRA KAY · 2003 to 2003
$221k
IRON ACQUISITION IN BORDETELLA PERTUSSISR29AI031088 · NIAID · EAST CAROLINA UNIVERSITY · PI ARMSTRONG, SANDRA KAY · 1991 to 1995
–
NIAID NIH HHS AI-31088NIAID NIH HHS R01 AI031088NIAID NIH HHS R21 AI031088
6 · The paper itself

Abstract

A previous study found that alcaligin siderophore production by Bordetella bronchiseptica strain RB50 is Bvg repressed. In contrast, we report that alcaligin production by RB50 does not require Bvg phenotypic phase modulation and that isogenic Bvg(Con) and Bvg(-) phase-locked mutants both produce alcaligin in response to iron starvation.

Indexed as

Hydroxamic AcidsBacterial ProteinsBordetella bronchisepticaChromatography, Thin LayerRepressor ProteinsSiderophoresTranscription FactorsVirulencealcaliginBacterial ProteinsBvgA protein, BacteriabvgS protein, Bordetella pertussisHydroxamic AcidsRepressor ProteinsSiderophoresTranscription Factors

Identifiers

PMID12446655
PMCPMC135483
OpenAlexW2145889406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.